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Abstract
Loss of mitochondrial membrane potential (DYm) is known to be closely linked to cell death by various insults. However,
whether acceleration of the DYm recovery process prevents cell necrosis remains unclear. Here we examined the hypothesis
that facilitated recovery of DYm contributes to cytoprotection afforded by activation of the mitochondrial ATP-sensitive K
+
(mKATP) channel or inactivation of glycogen synthase kinase-3b (GSK-3b). DYm of H9c2 cells was determined by
tetramethylrhodamine ethyl ester (TMRE) before or after 1-h exposure to antimycin A (AA), an inducer of reactive oxygen
species (ROS) production at complex III. Opening of the mitochondrial permeability transition pore (mPTP) was determined
by mitochondrial loading of calcein. AA reduced DYm to 1561% of the baseline and induced calcein leak from
mitochondria. DYm was recovered to 5163% of the baseline and calcein-loadable mitochondria was 661% of the control at
1 h after washout of AA. mKATP channel openers improved the DYm recovery and mitochondrial calcein to 7362% and
3067%, respectively, without change in DYm during AA treatment. Activation of the mKATP channel induced inhibitory
phosphorylation of GSK-3b and suppressed ROS production, LDH release and apoptosis after AA washout. Knockdown of
GSK-3b and pharmacological inhibition of GSK-3b mimicked the effects of mKATP channel activation. ROS scavengers
administered at the time of AA removal also improved recovery of DYm. These results indicate that inactivation of GSK-3b
directly or indirectly by mKATP channel activation facilitates recovery of DYm by suppressing ROS production and mPTP
opening, leading to cytoprotection from oxidant stress-induced cell death.
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Introduction
Mitochondrial membrane potential (DYm) is crucial for cell
viability. Loss of DYm by opening of the mitochondrial
permeability transition pore (mPTP) is a major mechanism of
myocardial infarction [1,2] and cerebral infarction [3] after
ischemia/reperfusion. Dissipation of DYm has also been shown to
precede shrinkage and fragmentation of cells, contributing to
programed cell death [4,5]. Loss of DYm by irreversible opening of
the mPTP leads to arrest of mitochondrial ATP synthesis,
mitochondrial swelling and outer membrane permeabilization.
During ischemia, DYm is temporarily maintained by consumption
of ATP by mitochondrial ATPase, and its recovery after
reperfusion depends on ischemia-induced injury of the mitochon-
drial machinery and on the level of stimuli for mPTP opening
upon reperfusion [6,7]. Involvement of mPTP opening and DYm
loss in reperfusion-induced cell death has been supported by
results of studies showing that protection against reperfusion injury
afforded by ischemic preconditioning (IPC) and IPC mimetics was
associated with inhibition of mPTP opening [1,8–11]. On the
other hand, few studies have examined if manipulation of DYm
recovery protects the heart.
A rationale for the hypothesis that acceleration of DYm recovery
protects cells from necrosis has been provided by several lines of
evidence. First, preserved DYm is necessary for mitochondrial
ATP synthesis, and recovery of ATP synthesis is crucial for
restoration of intracellular Na+ and Ca2+ homeostasis [5,7].
Second, there are differences between mitochondria within a cell
in susceptibility to Ca2+-induced mPTP opening, production of
reactive oxygen species (ROS) and structural changes after
ischemia/reperfusion [9,10]. ROS-induced ROS release and
Ca2+-induced Ca2+ release from mitochondria have been reported
as mechanisms of accelerated ROS production and Ca2+ overload
[12–14]. Hence, the recovery of DYm after withdrawal of insults is
also likely to be heterogeneous in mitochondria within a cell.
Third, mPTP opening is not always irreversible and re-closure of
mPTPs after reperfusion has been shown in rat hearts by use of
D-3H-2-deoxyglucose as a tracer of opened mPTPs [15,16],
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suggesting that recovery of DYm can be achieved by re-closure of
mPTPs. Collectively, these findings indicate the possibility that the
percentage of mitochondria with unrecoverable DYm within a cell
upon removal of an insult (for example, ischemia/reperfusion)
determines mortality of the cell.
We hypothesized that acceleration of DYm recovery by pro-
survival signaling protects myocytes from necrosis. To test this
hypothesis, we examined the time course of DYm recovery in
response to a period of exposure to ROS in H9c2 and C2C12 cells
and possible modification of the time course by activation of the
mitochondrial ATP-sensitive K+ (mKATP) channel and by
inhibition of glycogen synthase kinase-3b (GSK-3b). The mKATP
channel and GSK-3b were selected for testing effects on DYm as
these two localize within mitochondria and are known to play roles
in regulation of the threshold for mPTP opening [2,17,18].
Materials and Methods
Cell culture and experimental protocols
H9c2 cells, C2C12 cells and human embryonic kidney cells
(HEK-293 cells) were obtained from ATCC (American Type
Culture Collection). The cells were cultured in DMEM (4.5 g/L
glucose) supplemented with 10% fetal bovine serum and
antibiotics. All experiments using H9c2 and C2C12 cells were
started after serum deprivation for 24 h. An inhibitor of complex
III, antimycin A (AA, 40 mM), was used to induce mitochondrial
ROS generation. After 60-min treatment with AA, AA was
washed out from the culture medium by replacing the medium
with pre-warmed fresh medium without AA. Hypoxia/reoxygena-
tion was not employed to induce oxidant stress in this study, since
hypoxia alone reduces DYm and activates multiple pathways of
intracellular signaling, which complicates analysis of mPTP-
relevant signaling.
To examine the effects of activation of the mKATP channel, an
NO donor and inhibition of GSK-3b, H9c2 cells were incubated
with a vehicle, nicorandil (300 mM), diazoxide (300 mM), S-
nitroso-N-acetyl-DL-penicillamine (SNAP, 1 mM), or LiCl
(30 mM), for 1 h before addition of AA to the medium, and the
treatment was continued until the end of the experiment.
Treatment with 5-hydroxydecanote (5-HD, 100 mM) to inhibit
opening of the mKATP channel and treatment with mercaptopro-
pionyl glycine (MPG, 30 mM) to suppress ROS during nicorandil
treatment were commenced 30 min before treatment with a KATP
channel opener and discontinued with the onset of AA treatment.
To examine the possible effect of ROS on recovery of H9c2 cells,
MPG (30 mM) or N-acetyl-cysteine (NAC, 1 mM) was added to
the medium during AA treatment or to the medium after AA
treatment (i.e., a non-AA-containing medium). The effect of
inhibition of glycolysis was examined by use of iodoacetate (IAA,
30 mM).
Monitoring of mitochondrial membrane potential
Mitochondrial membrane potential was monitored by tetra-
methylrhodamine ethyl ester (TMRE) fluorescence as previously
reported [19,20]. H9c2 cells or C2C12 cells were loaded with
TMRE (100 nM) 1 h before AA treatment for assessing the effects
of AA on DYm or at the time of AA washout for assessing recovery
of DYm from oxidant stress by AA. Level of TMRE fluorescence
at each time point was expressed as percentage of values in time
controls without AA. Fluorescence was recorded by fluorescence
microscopy (Olympus IX-70), and images of TMRE fluorescence
taken at a magnification of 4006were quantified by pixel counts
after cutting off background fluorescence using a threshold value.
Data from three regions of interest (ROI) were averaged for each
well in the culture plate, and the numbers of cells within the ROI
were made comparable between treatment groups. In cells loaded
with TMRE after washout of AA, TMRE fluorescence level was
normalized by values of time controls in the same culture plate
since we had confirmed that TMRE fluorescence level did not
significantly change for 3 h of the control period.
Monitoring of mitochondrial permeability by calcein
In addition to TMRE, a membrane potential-independent
tracer, calcein, was used for detection of opening of the mPTP as
previously reported [21,22]. Briefly, in experiments in which the
effect of AA on the mPTP was examined, cells were incubated
with 0.25 mM calcein for 15 min, and the medium was changed to
calcein-free medium containing 4 mM of cobalt chloride (CoCl2)
before treatment with AA. In experiments in which mPTP
opening status after AA washout was examined, calcein was
loaded for 15 min immediately after washout of AA. The medium
was then replaced with a calcein-free medium containing 4 mM
CoCl2. Cells were pretreated with 1 mM MitoTracker red for
15 min to stain mitochondria before AA treatment. The calcein-
stained area overlapped with the MitoTraker red-stained area was
used as an index of mitochondria with closed mPTP and
quantified as the level of TMRE described above. Data were
normalized by time control cell data. In pilot experiments (n = 6),
MitoTracker red was found to be lost from some mitochondria
after AA treatment, and 68.366.2% of mitochondria retained
MitoTracker red at 60 min after washout of AA. Thus, the extent
of mPTP opening was somewhat underestimated by the present
method.
Isolation of mitochondria and cytosol fractions, Western
blotting, and immunoprecipitation
Mitochondrial and cytosolic fractions of H9c2 cells were
prepared by using a mitochondrial isolation kit (Pierce Biotech-
nology, Rockford, IL) according to the manufacturer’s protocol.
The samples were subjected to SDS-PAGE, followed by transfer to
a polyvinylidene difluoride membrane. After blocking with TBS-T
with 5% skim milk or 5% BSA, the membrane was incubated with
the primary antibody at 4uC overnight. After incubation with the
secondary antibody, the bands were visualized by a standard ECL
technique. Interaction of GSK-3b and Reiske was analyzed by
immunoprecipitation experiments. Precleared cell lysates (500 mg)
were incubated with 2 mg of anti-Rieske antibody in IP buffer
(20 mM Tris–HCl [pH 7.4], 1 mM EGTA, 5 mM NaN3, 50 mM
NaCl, 1 mM PMSF, 50 mM Na3VO4, 1% Triton X-100, 0.5%
NP-40 and a protease inhibitor cocktail) at 4uC overnight with
rotation. The antibody-Rieske complex was collected with magnet
beads and washed with IP buffer. The immunoprecipitates were
subjected to Western blotting as described above. Antibodies used
were rabbit monoclonal anti-GSK-3b (#9315, Cell Signaling),
rabbit polyclonal anti-phospho-(Ser9) GSK-3b (#9336, Cell
Signaling), rabbit polyclonal anti-glycogen synthase (#3893, Cell
Signaling), rabbit polyclonal anti-phospho-(Ser641/645) glycogen
synthase (44-1092G, Invitrogen), mouse monoclonal anti-Rieske
(ab14746, Abcam), goat polyclonal anti-ANT (sc-9299, Santa
Cruz), mouse monoclonal anti-VDAC1 (ab14734, Abcam), mouse
monoclonal anti-cyclophilin D (AP1035, Calbiochem), mouse
monoclonal anti-prohibitin (sc-56346, Santa Cruz), mouse mono-
clonal anti-b-actin (A5316, SIGMA) and rabbit polyclonal anti-
inorganic phosphate carrier (custom-made antibody [23]).
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Transfection of siRNA
Knockdown of GSK-3b was performed by transfection of
siRNA against rat GSK-3b (Mission siRNA, SA-
SI_Rn01_00035806, Sigma-Aldrich) using Nucleofection (Lonza
Walkersville, MD) according to the manufacturer’s protocol.
Experiments were completed 48 h after transfection.
Determination of cell necrosis and apoptosis
Cell necrosis was analyzed by determination of lactate
dehydrogenase (LDH) released into the incubation medium.
LDH activity in the culture medium and LDH activity in the
medium after freeze-thawing of the cells (total cellular LDH
activity) were measured by using a CytoTox 96 Non-Radioactive
Cytotoxicity assay kit (Promega, Madison, WI) according to the
manufacturer’s protocol. LDH activity in the medium as a
percentage of the total cellular LDH activity was used as an index
of cell necrosis. To quantify apoptosis, cells were stained with
Hoechst33342 as previously reported [24]. Apoptosis of cells was
defined as nuclear condensation revealed by Hoechst33342.
Determination of ROS production
Intracellular ROS levels were monitored by 29-79-dichloro-
fluorescein (DCF) fluorescence. H9c2 cells were loaded with DCF
according to the manufacturer’s protocol. DCF fluorescence was
recorded by FLoid Cell Imaging Station (Life Technologies, CA)
at 30 and 60 min after the start of incubation in an AA-containing
medium and at 15 and 60 min after washout of AA.
Determination of ATP level
H9c2 cells were subjected to 60-min treatment with AA
(40 mM), 120-min treatment with IAA (30 mM), combination of
AA and IAA treatments or 120-min treatment with a vehicle, and
their ATP levels were determined by an assay kit, CellTiter-Glo
Luminescent Cell Viability Assay G7570 (Promega, Madison,
USA).
Succinate dehydrogenase activity assay
Cells were subjected to 24-hour serum-deprived culture and
then incubated in AA (40 mM)-containing medium or normal
medium for 60 min with or without 300 mM nicorandil. For cells
treated with both AA and nicorandil, nicorandil was added to the
medium 60 min before the onset of incubation with AA. Cellular
succinate dehydrogenase (complex II) activity was measured by
using a Complex II Enzyme Activity Microplate Assay Kit
(Abcam, Cambridge, UK) according to the manufacturer’s
protocol.
Chemical compounds
AA, diazoxide, 5-HD, LiCl, MPG, and cyclosporine A were
purchased from Sigma Aldrich (St. Louis, MO). NAC was from
Wako Pure Chemical Industries (Osaka, Japan). Nicorandil was
provided by Chugai Pharmaceutical Co. Ltd. (Tokyo, Japan).
TMRE, calcein and DCF were purchased from Invitrogen
(Carlsbad, CA).
Statistical analysis
Data are presented as means 6 standard error of the mean.
One-way or two-way analysis of variance (ANOVA) was used to
detect significant differences between group means in the
treatment groups. When ANOVA indicated a significant overall
difference, multiple comparisons of the groups were performed by
the Student-Newman-Keuls post-hoc test. A difference was
considered to be statistically significant if p was less than 0.05.
Results
Activation of the mKATP channel promotes recovery of
DYm dissipated by AA
During treatment with AA, TMRE fluorescence was reduced to
15% of the control and the rod-shaped structure of mitochondria
became blurred, indicating reduction in DYm and mPTP opening
(Figure 1). At 60 min after washout of AA, the level of TMRE
fluorescence was 51% of the baseline (Figure 1B and C). Since AA
not only induces ROS generation but also inhibits oxidative
phosphorylation, both effects were possibly responsible for the
change in DYm. To assess the impact of ATP deletion on the time
course of DYm after AA treatment, we compared its effect with
those of IAA and AA+IAA. AA reduced ATP level to 23.961.2%
of vehicle controls, and a significantly greater reduction in ATP
level was achieved by IAA (13.060.4%). The combination of AA
and IAA almost completely depleted ATP (0.660.2%). Although
depletion of ATP was significantly less in the AA-treated group,
time courses of TMRE fluorescence were similar in the AA-treated
and IAA-treated groups (Figure 1D). Together with the effects of
ROS scavengers on TMRE fluorescence (see ‘‘Relationship
between ROS and recovery of DYm’’ below), these results indicate
that ROS, in addition to ATP depletion, was responsible for loss of
DYm. by AA treatment.
Opening of the mPTP by AA was indicated by the finding that
calcein loaded in mitochondria leaked into the cytosol after AA
treatment (Figure 2A). The ratio of mitochondria positive for
calcein was 6% of the baseline at 60 min after AA treatment, and
the ratios were 10% and 18% of time control value at 60 and
120 min after AA washout, respectively (Figure 2B and C). In the
vehicle-treated controls, the ratio of mitochondria positive for
calcein was not 100% (Figure 2C) since the threshold for calcein
fluorescence was set at a relatively high level in order to include
clearly discrete mitochondrial calcein.
Contribution of mPTP opening to reduction in TMRE
fluorescence and cell necrosis after washout of AA was supported
by results showing that cyclosporine A, a direct mPTP inhibitor,
attenuated the effect of AA treatment on TMRE fluorescence and
LDH release after AA washout by 24% (Figure 3). Protein levels of
putative regulatory subunits of the mPTP (adenine nucleotide
translocase, voltage-dependent anion channel, inorganic phos-
phate carrier and cyclophilin D) were not changed by AA (Figure
S1).
Pretreatment with an mKATP channel activator (nicorandil or
diazoxide) did not affect reduction of TMRE fluorescence during
AA treatment but significantly enhanced its recovery after washout
of AA (Figure 1B and C). This effect of mKATP channel openers
was abolished by 5-HD, an mKATP channel blocker (Figure 1B).
SNAP, an NO donor, did not mimic the effect of nicorandil on
TMRE fluorescence after AA treatment, indicating that the nitrate
property of nicorandil was not involved in its effect on DYm
(Figure S2). Although SNAP at relatively high doses (0.1–1 mM)
has been shown to activate the mKATP channel [25,26], we
selected a low dose (1 mM) to avoid the effect on the mKATP
channel in this study. Improvement by diazoxide in recovery of
TMRE fluorescence after washout of AA was also confirmed in
C2C12 cells (Figure 4), indicating that role of the mKATP channel
in DYm regulation is not unique to H9c2 cells.
Inhibition of GSK-3b by activation of the mKATP channel
Like diazoxide in our previous study [27], nicorandil increased
the levels of Ser9-phospho-GSK-3b in the mitochondria and
cytosol by 24% and 37%, respectively (Figure 5AB). Phosphory-
lation of GSK-3b in mitochondria by nicorandil was inhibited by
Recovery of DYm and Cell Protection
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MPG (Figure 5C), indicating that ROS generated by mKATP
channel activation [28,29] mediated GSK-3b phosphorylation.
Elevation of mitochondrial phospho-GSK-3b level by nicorandil
was maintained at 5 min after AA treatment, though the effect was
not significant afterwards (Figure 6A and B). If inactivation of
GSK-3b by phosphorylation at Ser9 contributes to facilitated
recovery of DYm after AA treatment by nicorandil, the effect of
nicorandil should be mimicked by an inhibitor of GSK-3b, LiCl,
and by knockdown of GSK-3b. That was indeed the case as shown
in Figure 6C and D. Inhibition of GSK-3b activity by LiCl was
confirmed by the results that LiCl increased Ser9-phospho-GSK-
3b level, reflecting suppression of a GSK-3b activity-dependent
phosphatase, and reduced phosphorylation of glycogen synthase
(GS), a downstream target of GSK-3b (Figure 6C, lower panel).
Relationship between ROS and recovery of DYm
The level of ROS determined by DCF was significantly elevated
during AA treatment and then decreased time-dependently after
washout of AA (Figure 7A and B). Treatment with nicorandil or
LiCl reduced the level of ROS during AA treatment and after AA
washout (Figure 7B). Although inhibition of the activity of
succinate dehydrogenase was reported as a mechanism by which
mKATP channel activation reduces ROS production in the heart
[30], succinate dehydrogenase activity in H9c2 cells was not
significantly changed by nicorandil or AA: 0.5360.11 (mOD/min)
in controls (vehicle-treated cells), 0.6160.07 in AA-treated cells,
0.6760.20 in nicorandil-treated cells and 0.6960.08 in nicorandil
plus AA-treated cells (n = 5 in each treatment).
To determine whether ROS during AA treatment or residual
ROS being produced after washout of AA inhibit recovery of
DYm, we tested the effects of an ROS scavenger during AA
treatment or after washout of AA. MPG (30 mM) added to the
medium only during AA treatment period significantly reduced
ROS both during and after AA treatment (Figure 7C). The effect
of MPG on ROS was associated with partial preservation of
TMRE fluorescence during AA treatment and improved recovery
of TMRE fluorescence (Figure 8A). Treatment with MPG or
NAC (1 mM) commenced at the time of washout of AA, which
reduced ROS level (Figure 7D), also significantly improved
recovery of TMRE fluorescence (Figure 8B), indicating contribu-
tion of persistent ROS production after washout of AA to
continual mPTP opening.
Effect of facilitated DYm recovery on cell necrosis and
apoptosis
LDH released into the medium was determined at the end of
AA treatment and at 2 h after AA removal with or without mKATP
channel opener pretreatment. As shown in Figure 9A, LDH
release at the end of AA treatment was not reduced by nicorandil
or diazoxide. However, LDH release after removal of AA was
significantly reduced by nicorandil, diazoxide and LiCl (Figure 9B
Figure 1. Effects of mKATP channel openers and a glycolysis inhibitor on antimycin A-induced loss of DYm and its recovery in H9c2
cells. A: TMRE images before and after antimycin A (AA) treatment (Images were from different cells). B and C: TMRE fluorescence in NC- (B) and DZ-
pretreated cells (C). D: TMRE fluorescence in IAA-treated cells. TMRE fluorescence in NC= nicorandil, DZ= diazoxide, 5-HD= 5-hydoxydecanote, IAA
= iodoacetate, Treatment = time after onset of treatment with AA, Washout = time after washout of AA. *p,0.05 vs. Vehicle+AA or AA, #p,0.05
vs. NC+AA. N= 8.
doi:10.1371/journal.pone.0112529.g001
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Figure 2. Effects of mKATP channel openers on antimycin A-induced mPTP opening and its recovery in H9c2 cells. A and B: Calcein and
MitoTracker images before (A) and after (B) antimycin A (AA) treatment. C and D: Levels of calcein-positive mitochondria 60 min after AA treatment
(C) and 60 and 120 min after washout of AA (D). Level of calcein-positive mitochondria is expressed as the ratio of calcein-positive area to
MitoTracker-positive area. *p,0.05 vs. Vehicle+AA, #p,0.05 vs. NC+AA.
doi:10.1371/journal.pone.0112529.g002
Figure 3. Effects of cyclosporine A on antimycin A-induced changes in DYm and LDH release. A: Level of TMRE fluorescence was
determined as an index of DYm. Cyclosporine A (CsA, 0.5 mM) was added to the medium 60 min before antimycin A (AA) treatment. AA-induced
reduction of TMRE fluorescence at 60 min after the onset of AA treatment was slightly attenuated in the CsA-treated group compared to that in the
AA group, indicating partial suppression of ROS-induced mPTP opening. Recovery of TMRE fluorescence at 60 min after washout of AA was also
slightly improved by CsA. N= 5 per group. B: LDH released after washout of AA was significantly reduced by CsA. *p,0.05 vs. Vehicle+AA. N = 8 per
group.
doi:10.1371/journal.pone.0112529.g003
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and C), and the protective effects of mKATP channel openers were
inhibited by 5-HD. Apoptosis after washout of AA was also
suppressed by nicorandil in a 5-HD-sensitive manner (Figure 9D
and E). Collectively, these results indicate that accelerated
recovery of DYm after oxidant stress by suppression of ROS
production via GSK-3b inactivation prevents cell necrosis and
apoptosis.
Modification of mitochondrial complex III by activation of
the mKATP channel
Since AA-induced ROS production was suppressed by LiCl or
nicorandil (Figure 7B), we examined the interaction of complex
III, a target for AA to generate ROS, and GSK-3b. Interaction of
a complex III subunit, Rieske protein (Rieske), and GSK-3b was
significantly increased by AA. The Rieske-GSK-3b interaction was
attenuated by mKATP channel openers in H9c2 cells and also in
HEK293 cells (Figure 10).
Discussion
The time course of DYm recovery or mPTP re-closure and their
relationships with development of tissue injury have not been
characterized. The present study showed that activation of the
mKATP channel (Figures 1BC and 4), reduction of GSK-3b
activity (Figure 6C and D) or suppression of persistent ROS
production (Figure 8B) significantly improved recovery of DYm
from ROS-induced dissipation. Furthermore, the improved DYm
recovery was associated with suppressed LDH release during the
recovery process and apoptosis (Figure 9). These results support
the notion that facilitation of DYm recovery protects cell from cell
death.
ROS production induced by AA, an inhibitor of complex III,
was suppressed by inactivation of GSK-3b (Figure 6), indicating
that this kinase enhanced ROS prodcution. Involvement of GSK-
3b in mitochondrial ROS production is not specific to AA-induced
ROS production. Our recent study has shown that mitochondrial
translocation of GSK-3b triggered by exogenous hydrogen
peroxide induced enhanced ROS production and that both
mitochonrial translocation of GSK-3b and ROS production were
dependent on GSK-3b kinase activity [20].
Since opening of the mPTP is a major mechanism of failure of
DYm recovery after ischemia/reperfusion [2,3,5,10], we assessed
the impact of mKATP channel activation on mPTP opening and
re-closure. As expected from massive ROS production by AA, the
level of mPTP opening was unaffected by activation of the mKATP
channel. While level of ROS production during AA treatment was
different between vehicle-treated and nicorandil-treated cells
(Figure 7B), TMRE fluorescence was similarly suppressed by AA
to 20% of baseline level in both treatment groups (Figure 1B),
suggesting presence of ROS threshold level for collapsing DYm.
However, level of the calcein-loadable mitochondria was higher in
the nicorandil-pretreated group at 60 and 120 min after washout
of AA (Figure 2D). Since MitoTracker red is a DYm-dependent
probe, use of this probe for identifying calcein localized in
mitochondria probably underestimated mitochondria with closed
mPTPs after washout of AA. In fact, MitoTracker positive area
was reduced to 70,80% of time control after AA treatment.
Nevertheless, there was a significant difference between levels of
Figure 4. Effects of an mKATP channel opener on antimycin A-
induced loss of DYm and its recovery in C2C12 cells. TMRE
fluorescence in untreated and diazoxide-pretreated cells. AA= anti-
mycin A, DZ= diazoxide, Treatment = time after onset of treatment
with AA, Washout = time after washout of AA. *p,0.05 vs. Vehicle+AA.
N = 8.
doi:10.1371/journal.pone.0112529.g004
Figure 5. Effects of nicorandil and LiCl on GSK-3b phosphor-
ylation. A: Representative Western blotting for Ser9-phospho-GSK-3b
and total GSK-3b in cytosolic and mitochondrial fractions of vehicle-
treated, nicorandil-treated (NC) and 5-hydroxydecanoate (5-HD) plus
NC-treated cells. B: Group means of mitochondrial Ser9-phospho-GSK-
3b levels. NC and 5-HD were added to the culture medium 60 min and
90 min before collection of cells for Western boltting, respectively. *p,
0.05 vs. Vehicle, {p,0.05 vs. NC+Vehicle. N = 8 per group. C: Effects of
MPG (mercaptopropionyl glycine) on the effect of NC-induced
phosphorylation of GSK-3b.
doi:10.1371/journal.pone.0112529.g005
Recovery of DYm and Cell Protection
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calcein-positive mitochondria in nicorandil-treated and untreated
cells. These findings are consistent with the notion that facilitated
re-closure of mPTPs by mKATP channel activation contributed to
improved recovery of DYm from ROS-induced collapse. Howev-
er, the possibility that improved preservation of respiratory chain
complexes was involved in better recovery of DYm, leading to
restoration of mPTP status, cannot be excluded.
As a possible mechanism by which nicorandil promoted re-
closure of the mPTP, we postulated that withdrawal of mPTP-
opening stimuli after washout of AA was facilitated by nicorandil.
Of the known mPTP opening factors [2], we focused on ROS and
found that nicorandil and a GSK-3b inhibitor, LiCl, suppressed
ROS production during AA treatment and after washout of AA.
The effects of these agents on ROS level are consistent with results
of previous studies showing that mKATP channel openers suppress
burst production of ROS upon reperfusion in isolated perfused
hearts [30,31] and that a mitochondria-targeting GSK-3b mutant
increased ROS production in SH-SY5Y cells [32]. Interestingly,
treatment with ROS scavengers only after removal of AA was
sufficient to reproduce the effects of pretreatment with nicorandil
or LiCl on DYm (Figure 8B). In contrast, suppression of ROS
during AA treatment resulted in parallel up-ward shift of TMRE
fluorescence throughout experiments (Figure 8A). These results
indicate that suppression of ROS production by inactivation of
Figure 6. Effects of inhibition of GSK-3b on antimycin A-induced changes in DYm and its recovery. A: Western blotting for Ser9-phospho-
and total GSK-3b in mitochondria, B: Effects of antimycin A (AA) on phospho-GSK-3b level. C: TMRE fluorescence after AA treatment in vehicle- and
LiCl-pretreated cells. Western blotting for Ser9-phospho-GSK-3b, total GSK-3b, Ser641/645-phospho-glycogen synthase (GS), non-phospho-GS and b-
actin (loading control) in total lysates of vehicle-treated and LiCl-treated cells. Treatments with 30 mM and 60 mM LiCl for 60 min induced
phosphorylation of GSK-3b and dephosphorylation of GS. Increased phosphorylation of GSK-3b by LiCl reflects reduced activity of protein
phosphatase 1, which is positively regulated by GSK-3b activity. D: TMRE fluorescence after AA treatment in control siRNA- and GSK-3b-siRNA-
pretreated cells. NC= nicorandil. Treatment = time after onset of treatment with AA, Washout = time after washout of AA. *p,0.05 vs. Vehicle or
Control siRNA. N= 8.
doi:10.1371/journal.pone.0112529.g006
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GSK-3bmediates facilitation of DYm recovery, possibly via mPTP
re-closure, by mKATP channel activation.
Nicorandil induced phosphorylation of GSK-3b at Ser9 in
H9c2 cells (Figures 5 and 6) as did diazoxide in the rat
myocardium in vivo [27], though its level declined during AA
treatment. Interestingly, despite its transient effect on GSK-3b
during the early phase of AA treatment, nicorandil improved
recovery of DYm similarly to inactivation of GSK-3b by LiCl
throughout the AA treatment period (Figure 1). Hence, a signal
mechanism downstrem of this kinase needs to be postulated for
suppression of ROS production. However, relationships between
mitochondrial GSK-3b and molecules regulating ROS production
Figure 7. ROS generated by antimycin A. A: Representative DCF images. B: DCF fluorescence during and after antimycin A (AA) treatment in
vehicle-, NC- and LiCl-pretreated cells. C: Effects of MPG administered during AA treatment on DCF. D: Effects of MPG or NAC treatment commenced
at the time of AA washout on DCF. MPG-Tx = treatment with mercaptopropionyl glycine (MPG) during AA treatment, MPG= MPG treatment
commenced at the time of AA washout, NAC= N-acetylcysteine treatment commenced at the time of AA washout. Treatment = time after onset of
treatment with AA, Washout = time after washout of AA. *p,0.05 vs. Vehicle+AA or AA+Vehicle. N = 8.
doi:10.1371/journal.pone.0112529.g007
Figure 8. Effects of ROS scavengers on time course of DYm. A and B: Effects of MPG administered during AA treatment (A) and effects of
treatment with MPG or NAC commenced at the time of AA washout (B) on TMRE fluoresence. MPG-Tx = treatment with mercaptopropionyl glycine
(MPG) during AA treatment, MPG = MPG treatment commenced at the time of AA washout, NAC = N-acetylcysteine treatment commenced at the
time of AA washout. Treatment = time after onset of treatment with AA, Washout = time after washout of AA. *p,0.05 vs. AA+Vehicle. N = 8.
doi:10.1371/journal.pone.0112529.g008
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or ROS elimination remain unclear. A possible explanation is
involvement of GSK-3b in persistent ROS production triggered
by inhibitionn of comlex III at the Qi site. Recent studies by Viola
et al. [33,34] indicated that transient exposure of cardiomyocytes
to hydrogen peroxide induced persistent ROS production by
modification of the Qo site of complex III. In addition, ROS-
induced ROS release, which potentially leads to chain reactions of
mitochondrial ROS production, has been reported [14]. Hence, it
is possible that inactivation of GSK-3b during the early phase of
AA treatment has some impact on the level of persistent ROS
production afterwards. Although inhibition of succinate dehydro-
genase activity has been reported as a mechanism of ROS
suppression by mKATP channel openers in rat mitochondria [30],
we could not detect a significant change in succinate dehydroge-
nase activity by nicorandil in the present H9c2 cell preparation.
The mechanism by which inactivation of GSK-3b suppresses
ROS production remains unclear. Interestingly, we found that
interaction of GSK-3b with complex III was induced by AA in
association with ROS production and that mKATP channel
openers suppressed both GSK-3b-Rieske interaction and ROS
production by AA. AA induces ROS production by interaction
with the Qi site of the cytochrome bc1 complex, and Rieske is
involved in ROS production in complex III [35–37]. Reiske is a
major subunit of complex III, and its deletion does not prevent
assembly of other submits but abolishes enzymatic activity [37].
Deletion of Rieske also leads to reduction in protein levels of
complexes I and IV. ROS production in mitochondria are
reportedly increased by Rieske knockout fibroblasts [37], but ROS
production during hypoxia in pulmonary artery smooth muscle
cells has been shown to be reduced by deletion of Rieske [36].
Modification of the expression levels of complexes I and IV may
be involved in the apparently opposite effects of deletion of Rieske
on ROS production.
GSK-3b translocates from the cytosol to mitochondria and
interacts with adenine nucleotide translocase, a protein in the
mitochondrial inner membrane, after ischemia/reperfusion
[20,38]. A role of GSK-3b translocated to mitochondria in ROS
production is supported by the finding that selective expression of
unregulated GSK-3b in mitochondria significantly increased ROS
production in SH-SY5Y cells [32]. However, whether GSK-3b-
Rieske interaction is indeed causally related to ROS production at
complex III remains to be tested in future projects.
There are limitations in the present study. First, cell necrosis
induced by the present dose of AA was modest, and the impact of
Figure 9. Necrosis and apoptosis after antimycin A treatment. A–C: Cell necrosis indicated by LDH release. LDH release at the end of AA
treatment (A) and during a 2-h period after washout of AA (B, C) are shown. D and E: representative images of nuclear staining with Hoechst33342 (D)
and apoptosis at 2 h after washout of AA (E). AA= antimycin A, NC= nicorandil, DZ= diazoxide, 5-HD = 5-hydroxydecanoate. *p,0.05 vs. Vehicle,
{p,0.05 vs. Vehicle+AA. N = 8,12.
doi:10.1371/journal.pone.0112529.g009
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improvement of DYm recovery on cell survival has not been
characterized fully. However, this is a technical limitation and
larger doses of AA used in preliminary experiments increased
massive cell necrosis during AA treatment, making it difficult to
analyze recovery of DYm in cells that survived after washout of
AA. Second, levels of mPTP opening after washout of AA
(Figure 2D) determined by the present method are presumably
underestimated since MitoTracker red, a marker of mitochondria,
was lost from some mitochondria during AA treatment. However,
a significant increase in the percentage of calcein-positive
mitochondria after washout of AA was shown, and the results
still support the notion that mPTPs re-close after withdrawal of
oxidant stress. Third, we mainly used H9c2 cells, a rat
cardiomyoblast cell line, and it is unclear whether the present
results can be extrapolated to adult cardiomyocytes. However, the
effects of mKATP channel activation on DYm recovery and on
Rieske-GSK-3b interaction were also observed in C2C12 cells and
HEK293 cells, respectively, excluding the possibility that response
of DYm to ROS and its modification by activation of the mKATP
channel is unique to H9c2 cells.
In conclusion, the results indicate that facilitated recovery of
DYm from ROS-induced injury can be achieved by inactivating
GSK-3b directly or indirectly by activation of the mKATP channel
in isolated cardiomyocytes. The improvement of DYm recovery
protects cardiomyocytes from necrosis by burst production of
ROS. Significance of this mechanism in the myocardium in vivo
remains to be investigated.
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